Table 6.

. Relationship between type of brachytherapy and late GI, vaginal and GU toxicity

Type of Brachytherapy	Late GI toxicity ≥ G1	P-value	Late GI toxicity ≥ G2	P-value	Late GI toxicity ≥ G3	P-value
ICBT (280)	67 (23.9%)	0.026*	28 (10%)	0.838	10 (3.6%)	0.940
HBT (189)	63 (33.3%)		20 (10.6%)		7 (3.7%)
	Late Vaginal toxicity ≥ G1		Late Vaginal toxicity ≥ G2		Late Vaginal toxicity ≥ G3
ICBT (280)	18 (6.4%)	<0.001*	5 (1.8%)	0.034*	4 (1.4%)	0.412
HBT (189)	35 (18.5%)		10 (5.3%)		4 (2.1%)
	Late GU toxicity ≥ G1		Late GU toxicity ≥ G2		Late GU toxicity ≥ G3
ICBT (280)	45 (16.1%)	0.805	24 (8.6%)	0.375	4 (1.4%)	0.271
HBT (189)	32 (16.9%)		12 (6.3%)		5 (2.6%)

ICBT: intracavitary brachytherapy

HBT: hybrid brachytherapy

GI toxicity: gastrointestinal toxicity

GU toxicity: genitourinary toxicity

^*Statistical significance was defined as a P-value of <0.05.